An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2020
Authors
Gurka Matthew J., Mack Jasmine A., Chi Xiaofei, DeBoer Mark D.
Studies

Abstract

Non-alcoholic steatohepatits (NASH), which can lead to liver failure, requires liver biopsies to follow and is difficult to treat. Our goal was to assess metabolic syndrome (MetS) severity as a predictor of treatment success and a marker of response.